Theme:Frontier in Oncology Therapy
Opening Remarks
 |
Osamu Nagayama
Chairman Chugai Academy for Advanced Oncology |
1. Non-genetic dysregulation in tumor
 |
- Speaker:
- Kohei Miyazono, MD, PhD
The University of Tokyo, Japan
- Chair:
- Bruce A.Chabner, MD
Harvard Medical School, USA
|
 |
 |
- Speaker:
- Chi Van Dang, MD, PhD
The University of Pennsylvania, USA
- Chair:
- Kohei Miyazono, MD, PhD
The University of Tokyo, Japan
|
 |
2. Genetic dysregulation in tumor
 |
- Speaker:
- Mark Sliwkowski, PhD
Genentech Inc., USA
- Chair:
- Masakazu Toi, MD, PhD
Kyoto University, Japan
|
 |
 |
- Speaker:
- David B. Solit, MD
Memorial Sloan-Kettering Cancer Center, USA
- Chair:
- Hiroyuki Mano, MD, PhD
The University of Tokyo, Japan
|
 |
 |
- Speaker:
- Ross L. Levine, MD
Memorial Sloan-Kettering Cancer Center, USA
- Chair:
- Yuko Kitagawa, MD, PhD
Keio University, Japan
|
 |
3. Tumor immunotolerance : basic and applications
 |
- Speaker:
- James P. Allison, PhD
The University of Texas, USA
- Chair:
- Makoto Ogawa, MD
Emeritus President, Aichi Cancer Center, Japan
|
 |
 |
- Speaker:
- Padmanee Sharma, MD, PhD
The University of Texas, USA
- Chair:
- Kiyohiko Hatake, MD, PhD
Cancer Institute Hospital, JFCR, Japan
|
 |
4. Right drugs on right patients
 |
- Speaker:
- Neal Rosen, MD, PhD
Memorial Sloan-Kettering Cancer Center,USA
- Chair:
- Mitsuaki Yoshida, PhD
Cancer Chemotherapy Center, JFCR, Japan
|
 |
 |
- Speaker:
- Howard I. Scher, MD
Memorial Sloan-Kettering Cancer Center, USA
- Chair:
- Patrick G. Johnston, MD, PhD
The Queen´s University of Belfast, UK
|
 |
 |
- Speaker:
- Pasi A. Jänne, MD, PhD
Harvard Medical School, USA
- Chair:
- Nagahiro Saijo, MD, PhD
Japanese Society of Medical Oncology, Japan
|
 |
 |
- Speaker:
- Patrick G.Johnston, MD, PhD
The Queen´s University of Belfast, UK
- Chair:
- Chikashi Ishioka, MD
Tohoku University, Japan
|
 |
5. Accessibility to new drugs
 |
- Speaker:
- Bruce A. Chabner, MD
Harvard Medical School, USA
- Chair:
- Isao Kamae, MD, ScD
The University of Tokyo, Japan
|
 |
 |
- Speaker:
- Isao Kamae, MD, ScD
The University of Tokyo, Japan
- Chair:
- Yasuhiro Fujiwara, MD, PhD
National Cancer Center, Japan
|
 |
Discussion
 |
- Chair:
- Bruce A. Chabner, MD
Harvard Medical School, USA
|
|